Business Description
Vitaminka AD
ISIN : MKVITA101012
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.37 | |||||
Debt-to-EBITDA | 4.57 | |||||
Interest Coverage | 2.81 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.8 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EBITDA Growth Rate | 21.1 | |||||
3-Year EPS without NRI Growth Rate | 40.6 | |||||
3-Year Book Growth Rate | 8.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 85.44 | |||||
9-Day RSI | 51.88 | |||||
14-Day RSI | 38.08 | |||||
6-1 Month Momentum % | 0.91 | |||||
12-1 Month Momentum % | -6.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.39 | |||||
Quick Ratio | 0.66 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 125.56 | |||||
Days Sales Outstanding | 63.8 | |||||
Days Payable | 79.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.96 | |||||
Dividend Payout Ratio | 0.28 | |||||
Forward Dividend Yield % | 3.96 | |||||
5-Year Yield-on-Cost % | 3.96 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 13.39 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.62 | |||||
Operating Margin % | 5.73 | |||||
Net Margin % | 3.27 | |||||
FCF Margin % | 4.78 | |||||
ROE % | 10.39 | |||||
ROA % | 3.51 | |||||
ROIC % | 6.68 | |||||
ROC (Joel Greenblatt) % | 8.37 | |||||
ROCE % | 9.03 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 6.66 | |||||
PE Ratio without NRI | 6.99 | |||||
Shiller PE Ratio | 16.72 | |||||
Price-to-Owner-Earnings | 4.12 | |||||
PEG Ratio | 0.47 | |||||
PS Ratio | 0.22 | |||||
PB Ratio | 0.67 | |||||
Price-to-Tangible-Book | 0.68 | |||||
Price-to-Free-Cash-Flow | 4.54 | |||||
Price-to-Operating-Cash-Flow | 2.73 | |||||
EV-to-EBIT | 11.66 | |||||
EV-to-EBITDA | 6.77 | |||||
EV-to-Revenue | 0.66 | |||||
EV-to-FCF | 13.78 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.38 | |||||
Price-to-Graham-Number | 0.46 | |||||
Earnings Yield (Greenblatt) % | 8.58 | |||||
FCF Yield % | 21.93 | |||||
Forward Rate of Return (Yacktman) % | -13.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vitaminka AD Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MKD) | 3,443.107 | ||
EPS (TTM) (MKD) | 1515.747 | ||
Beta | 0 | ||
Volatility % | 18.64 | ||
14-Day RSI | 38.08 | ||
14-Day ATR (MKD) | 0.380244 | ||
20-Day SMA (MKD) | 10100.55 | ||
12-1 Month Momentum % | -6.9 | ||
52-Week Range (MKD) | 10000 - 10999 | ||
Shares Outstanding (Mil) | 0.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vitaminka AD Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vitaminka AD Stock Events
Event | Date | Price(MKD) | ||
---|---|---|---|---|
No Event Data |
Vitaminka AD Frequently Asked Questions
What is Vitaminka AD(XMAE:VITA)'s stock price today?
When is next earnings date of Vitaminka AD(XMAE:VITA)?
Does Vitaminka AD(XMAE:VITA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |